Clinical Trial Update: Investigation of the Effect of Nintedanib on the Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Patients With Non-small Cell Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating how nintedanib affects pharmacokinetics of ethinylestradiol and levonorgestrel in patients with non-small cell lung cancer; study termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Ethinylestradiol/Levonorgestrel (ethinylestradiol/levonorgestrel)
• Nintedanib (nintedanib)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 1 | Status: TERMINATED | Results posted: 2019-03-14